Last reviewed · How we verify
V-306 candidate vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
V-306 candidate vaccine (V-306 candidate vaccine) — Virometix.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| V-306 candidate vaccine TARGET | V-306 candidate vaccine | Virometix | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- V-306 candidate vaccine CI watch — RSS
- V-306 candidate vaccine CI watch — Atom
- V-306 candidate vaccine CI watch — JSON
- V-306 candidate vaccine alone — RSS
Cite this brief
Drug Landscape (2026). V-306 candidate vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/v-306-candidate-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab